Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

‘Listening to the people’: Beth Macy on the opioids crisis and her Dopesick sequel, Raising Lazarus

What’s next, the author asks, now the US has ‘a generation of users that started with heroin and fentanyl’

The Guardian - US

How science is getting closer to a world without animal testing

New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice

Financial Times

LGVN: Quarterly Report Provides Good News

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

UK decision not to buy Covid drug Evusheld disappoints charities

Drug can help prevent infection in people who are immunocompromised but government says data is lacking

The Guardian - UK

Germany: EU could OK combined COVID vaccines next month

Germany’s health minister says European Union drug regulators may authorize the use of vaccines that are effective against two variants of the coronavirus

The Independent UK

Johnson & Johnson to stop selling talc-based baby powder after cancer claims

Around 38,000 customers have filed lawsuits against the healthcare giant

The Independent UK

Johnson & Johnson to stop selling talc-based baby powder globally

Last year the company halted sales in the US and Canada

Dublin Live

Read news from The Economist, FT, and more,
with one subscription

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…

Benzinga

Monkeypox vaccine maker warns Biden administration against strategy to stretch supply

Plan to multiply 440,000 doses into 2 million is ‘safe and effective’ and will go ahead says HHS secretary

The Independent UK

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

Benzinga

Warning over shortage of medicines in UK including drugs for pain and cancer

Wales Online

Dublin study shows injecting cocaine has re-emerged as worrying trend

The study involved obtaining 155 used syringes from the Dublin and Midlands Region to identify what’s happening on the ground

Dublin Live

Walgreens fueled San Francisco's opioid crisis with thousands of 'suspicious orders,' judge rules

Walgreens helped fuel the opioid epidemic in San Francisco by shipping hundreds of thousands of "suspicious orders" of prescription drugs to its pharmacies, a federal judge ruled Wednesday.

Los Angeles Times

Senate’s Medicare drug pricing may ripple into private market

Congress is on the verge of passing historic drug pricing legislation that would allow the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift those costs to the private market.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Pharmacists ‘concerned’ over medicine shortages

More than half of those surveyed for the Pharmaceutical Journal believed patients had been put at risk in the last six months due to shortages.

The Independent UK

Judge: Walgreens contributed to San Francisco opioid crisis

A federal judge has ruled that Walgreens can be held responsible for contributing to San Francisco’s opioid crisis for over-dispensing opioids for years without proper oversight and failing to identify and report suspicious orders as required by law

The Guardian - US

Walgreens played ‘substantial’ role in San Francisco opioid crisis, judge finds

The pharmacy chain failed to properly investigate suspicious opioid orders, according to federal ruling

StockNews.com

1 Biotech Stock Investors Will Want to Buy This Week

Gilead Sciences (GILD), a biopharmaceutical company, reported strong demand across its HIV portfolio and raised its full-year guidance. Given the company’s robust profitability and discounted valuation, we think it could be wise to buy the stock now. Read on….

Get all your
news in one place.

100's of premium titles.
One news app.

Reuters

Exclusive-Rotavirus childhood vaccine shortage hits four African countries

Supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, officials close to the roll-out told Reuters, after disruptions at drugmaker GSK.

Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Dynamite News

CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

Corbevax booster for heterologous first has been approved by the Centre.Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E's CORBEVAX as a heterologous booster for adults above 18 yrs old. Read more on Dynamite News:

Al Jazeera

White House announces steps to boost monkeypox vaccine supply

The FDA has issued emergency authorisation for a dosage technique that would allow more shots of vaccine per vial.

Benzinga

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Reuters

Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups

Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said.

The Hindu

Key leprosy drug shortage in India is not of recent origin

Pharmaceutical pricing authority discussed issue in 2019, show documents

1 … 137 138 139 140

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.